2-arylamino-pyrimidines for the treatment of GSK3-related disorders
US7078410B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2002 |
| Grant date | Jul 18, 2006 |
| Priority date | — |
| Expiry date | Mar 28, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous solution for prophylactic treatment of teats of lactating mammals, comprising as a first component at least partially deacetylated chitosan, or an acid addition salt thereof, in a concentration of up to about 2% by weight of chitosan, the solution having a pH of from about 4 to about 6.8, and said first component having a molecular weight such that the viscosity of the solution is less than about 50 mPas; and a method of prophylactic treatment of teats of lactating mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.